2 results match your criteria: "CA. Stanford Cardiovascular Institute[Affiliation]"
Immune Cellular Dynamics in the Peripheral Blood: A Barometer for Cardiovascular Risk?
Circ Genom Precis Med
June 2024
Division of Cardiovascular Medicine, Department of Medicine, Stanford University, CA. Stanford Cardiovascular Institute, CA.
A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease.
Int J Cardiol
May 2017
Heart Research Institute, 7 Eliza Street, Newtown, NSW 2042, Australia; Sydney Medical School, University of Sydney, Camperdown, NSW 2006, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia. Electronic address:
Background: Endothelial cells derived from human induced pluripotent stem cells (iPSC-ECs) promote angiogenesis, and more recently induced endothelial cells (iECs) have been generated via fibroblast trans-differentiation. These cell types have potential as treatments for peripheral arterial disease (PAD). However, it is unknown whether different reprogramming methods produce cells that are equivalent in terms of their pro-angiogenic capabilities.
View Article and Find Full Text PDF